Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,007 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Duloxetine for Multiple Sclerosis Pain

NCT00755807

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)

NCT00395200

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +8 more
Locations
  • University of Cambridge Dept of Clinical Neurosciences Cambridge, Cambridgeshire, United Kingdom
  • University College London Institute of Neurology London, United Kingdom
View Trial Details
Completed

Zenapax to Treat Multiple Sclerosis

NCT00001934

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis

NCT00053417

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +12 more
Locations
  • Barrow Neurological Institute at St. Joseph Hospital and Medical Center Phoenix, Arizona, United States
  • USC MS Comprehensive Care Center Los Angeles, California, United States
  • Yale University MS Center New Haven, Connecticut, United States
  • Shepherd Center Atlanta, Georgia, United States
View all 25 locations
View Trial Details

Related conditions